Effect of Subcision and Suction on Acne Scars

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Murad Alam, Northwestern University
ClinicalTrials.gov Identifier:
First received: September 14, 2012
Last updated: July 16, 2013
Last verified: July 2013

The primary objective of this study is to determine whether the use of standard treatment in conjunction with suction will improve acne scars compared to a standard treatment alone.

Condition Intervention
Acne Scars
Procedure: Suction
Procedure: Subcision

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Pilot Split Face Randomized, Evaluator Blinded Study on the Effect of Subcision and Suctioning With a Microdermabrasion Device on Rolling Acne Scars

Resource links provided by NLM:

Further study details as provided by Northwestern University:

Primary Outcome Measures:
  • Change in acne scarring compared to baseline after treatments [ Time Frame: Baseline and 4 months ] [ Designated as safety issue: No ]
    The change in acne scarring is measured using a global scarring grading system to compare baseline scarring to the treatments.

Estimated Enrollment: 20
Study Start Date: September 2012
Estimated Study Completion Date: September 2015
Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Subcision & Suction
Standard treatment for acne scars followed by suction.
Procedure: Suction Procedure: Subcision
Active Comparator: Subcision
Standard treatment for acne scars only
Procedure: Subcision


Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Age 18 and over
  • Have bilateral rolling acne scars
  • Are in good health
  • Subject has the willingness and ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

Exclusion Criteria:

  • Under 18 years of age
  • Pregnancy or lactation
  • Unable to understand the protocol or give informed consent
  • Has mental illness
  • Recent Accutane use in the past 6 months
  • Prone to hypertrophic and keloidal scarring
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01696513

United States, Illinois
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Principal Investigator: Murad Alam, MD Northwestern University
  More Information

No publications provided

Responsible Party: Murad Alam, Professor in Dermatology, Otolaryngology- Head and Neck Surgery, and Surgery-Organ Transplantation, Northwestern University
ClinicalTrials.gov Identifier: NCT01696513     History of Changes
Other Study ID Numbers: STU66710
Study First Received: September 14, 2012
Last Updated: July 16, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Acne Vulgaris
Acneiform Eruptions
Skin Diseases
Facial Dermatoses
Sebaceous Gland Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on April 23, 2014